ATXS – astria therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "outperform" rating re-affirmed by analysts at Wedbush.
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Form 4 Astria Therapeutics, For: Mar 21 Filed by: Matthews Andrea
Form 4 Astria Therapeutics, For: Mar 21 Filed by: Komjathy Andrew
Form 4 Astria Therapeutics, For: Mar 21 Filed by: Milne Jill C.
Form 4 Astria Therapeutics, For: Mar 21 Filed by: Clauser Noah
Form 4 Astria Therapeutics, For: Mar 21 Filed by: Harshbarger Benjamin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.